Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 May;48(5):433–437. doi: 10.1136/jcp.48.5.433

Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.

M Beuzelin-Yvraut 1, A Bourguignat 1, E Phillips 1, A Roseto 1, E Osinaga 1
PMCID: PMC502619  PMID: 7629290

Abstract

AIMS--To determine whether the monoclonal antibody (MoAb) 83D4, previously shown to be highly specific for carcinoma cells, can be used as an immunocytological marker to discriminate between benign and malignant cells in serous effusions; and to test for a correlation between expression of the antigen reacting with MoAb 83D4 on effusion cells and the amount of soluble 83D4 antigen in effusion fluids. METHODS--Thirty three pleural and 23 peritoneal effusions from 56 cancer patients with metastatic disease were tested for the presence of Tn associated 83D4 antigen by immunocytochemical staining, and for the presence of soluble antigen in supernatants. The patients had undergone various chemotherapy and radiation therapy protocols. RESULTS--As a result of the various types of treatment, the cytological characteristics of the cells were often modified and the antigenic epitopes may have been altered. Positive staining for 83D4 MoAb was obtained in 36 (97%) of the 37 malignant effusions, eight (73%) of 11 suspect effusions, and three (38%) of the eight apparently benign effusions (free of malignant cells). In these latter cases, cytological reassessment showed a few suspect cells in two cases. 83D4 soluble antigen was detected in 30 of 37 malignant effusions (81%), five of 11 suspected infusions (46%), and five of eight apparently benign effusions (63%). CONCLUSIONS--Immunocytochemical staining with anti-83D4 antibody is useful for differentiating reactive or atypical mesothelial cells from epithelial cells, especially in breast cancer effusions.

Full text

PDF
435

Images in this article

435Image
on p.435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betta P. G., Pavesi M., Pastormerlo M., Tallarida F., Bellingeri D., Bocca R. Use of monoclonal antibody B72.3 as a marker of metastatic carcinoma cells in neoplastic effusions. Pathologica. 1991 Jan-Feb;83(1083):99–104. [PubMed] [Google Scholar]
  2. Charpin C., Pancino G., Osinaga E., Bonnier P., Lavaut M. N., Allasia C., Roseto A. Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution and microcytophotometric analysis of immunoprecipitates on tissue sections. Anticancer Res. 1992 Jan-Feb;12(1):209–223. [PubMed] [Google Scholar]
  3. Daste G., Serre G., Mauduyt M. A., Vincent C., Caveriviere P., Soleilhavoup J. P. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions. Cytopathology. 1991;2(1):19–28. doi: 10.1111/j.1365-2303.1991.tb00380.x. [DOI] [PubMed] [Google Scholar]
  4. Epenetos A. A., Canti G., Taylor-Papadimitriou J., Curling M., Bodmer W. F. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet. 1982 Nov 6;2(8306):1004–1006. doi: 10.1016/s0140-6736(82)90047-2. [DOI] [PubMed] [Google Scholar]
  5. Esteban J. M., Yokota S., Husain S., Battifora H. Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis. Am J Clin Pathol. 1990 Dec;94(6):698–705. doi: 10.1093/ajcp/94.6.698. [DOI] [PubMed] [Google Scholar]
  6. Flynn M. K., Johnston W., Bigner S. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies. Acta Cytol. 1993 Jul-Aug;37(4):439–447. [PubMed] [Google Scholar]
  7. García-González M., Bettinger S., Ott S., Olivier P., Kadouche J., Pouletty P. Purification of murine IgG3 and IgM monoclonal antibodies by euglobulin precipitation. J Immunol Methods. 1988 Jun 28;111(1):17–23. doi: 10.1016/0022-1759(88)90054-3. [DOI] [PubMed] [Google Scholar]
  8. Ghosh A. K., Spriggs A. I., Taylor-Papadimitriou J., Mason D. Y. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Pathol. 1983 Oct;36(10):1154–1164. doi: 10.1136/jcp.36.10.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gioanni J., Caldani C., Zanghellini E., Mazeau C., Duplay H., Ferrua B., Schneider M. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions. Acta Cytol. 1991 May-Jun;35(3):315–319. [PubMed] [Google Scholar]
  10. Hakomori S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res. 1989;52:257–331. doi: 10.1016/s0065-230x(08)60215-8. [DOI] [PubMed] [Google Scholar]
  11. Johnston W. W., Szpak C. A., Lottich S. C., Thor A., Schlom J. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions. Cancer Res. 1985 Apr;45(4):1894–1900. [PubMed] [Google Scholar]
  12. Johnston W. W. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer. 1985 Aug 15;56(4):905–909. doi: 10.1002/1097-0142(19850815)56:4<905::aid-cncr2820560435>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  13. Kjeldsen T., Clausen H., Hirohashi S., Ogawa T., Iijima H., Hakomori S. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 1988 Apr 15;48(8):2214–2220. [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Latza U., Niedobitek G., Schwarting R., Nekarda H., Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol. 1990 Mar;43(3):213–219. doi: 10.1136/jcp.43.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Osinaga E., Pancino G., Beuzelin M., Babino A., Rodriguez D., Robello C., Tiscornia A., Phillips E., Bourguignat A., Roseto A. Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma. Cancer. 1992 Apr 1;69(7):1745–1749. doi: 10.1002/1097-0142(19920401)69:7<1745::aid-cncr2820690716>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  17. Osinaga E., Pancino G., Porchet N., Berois N., De Cremoux P., Mistro D., Aubert J. P., Calvo F., Roseto A. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant. Breast Cancer Res Treat. 1994;32(2):139–152. doi: 10.1007/BF00665765. [DOI] [PubMed] [Google Scholar]
  18. Pancino G. F., Osinaga E., Vorauher W., Kakouche A., Mistro D., Charpin C., Roseto A. Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method. Hybridoma. 1990 Aug;9(4):389–395. doi: 10.1089/hyb.1990.9.389. [DOI] [PubMed] [Google Scholar]
  19. Pancino G., Osinaga E., Charpin C., Mistro D., Barque J. P., Roseto A. Purification and characterisation of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by monoclonal antibody 83D4. Br J Cancer. 1991 Mar;63(3):390–398. doi: 10.1038/bjc.1991.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shaw P., Buckman R., Law J., Baumal R., Marks A. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies. Tumour Biol. 1988;9(2-3):101–109. doi: 10.1159/000217550. [DOI] [PubMed] [Google Scholar]
  21. Singhal A., Hakomori S. Molecular changes in carbohydrate antigens associated with cancer. Bioessays. 1990 May;12(5):223–230. doi: 10.1002/bies.950120506. [DOI] [PubMed] [Google Scholar]
  22. Springer G. F. T and Tn, general carcinoma autoantigens. Science. 1984 Jun 15;224(4654):1198–1206. doi: 10.1126/science.6729450. [DOI] [PubMed] [Google Scholar]
  23. Stoop J. A., Hendriks J. G., Berends D. Identification of malignant cells in serous effusions using a panel of monoclonal antibodies Ber-EP4, MCA-b-12 and EMA. Cytopathology. 1992;3(5):297–302. doi: 10.1111/j.1365-2303.1992.tb00051.x. [DOI] [PubMed] [Google Scholar]
  24. Szpak C. A., Johnston W. W., Lottich S. C., Kufe D., Thor A., Schlom J. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions. Acta Cytol. 1984 Jul-Aug;28(4):356–367. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES